| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.00B | -9.3% | +10.8% |
| Cost of Revenue | $21.41B | -12.0% | +12.3% |
| Gross Profit | $5.59B | +2.7% | +5.4% |
| R&D Expense | $752.0M | -4.2% | +0.9% |
| SG&A Expense | $2.72B | -5.8% | -5.9% |
| Operating Income | $2.12B | +19.5% | +27.0% |
| Pre-tax Income | $1.94B | +34.8% | +39.4% |
| Income Tax | $393.0M | +42.4% | +48.3% |
| Net Income | $1.55B | +33.0% | +36.7% |
| EPS (Basic) | $2.31 | +34.3% | +43.5% |
| EPS (Diluted) | $2.28 | +34.1% | +44.3% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.57B | +17.5% | +83.1% |
| Accounts Receivable | $11.72B | -22.0% | +4.8% |
| Inventory | $6.95B | -3.6% | +4.5% |
| Current Assets | $43.10B | -5.3% | +13.3% |
| Total Assets | $87.48B | -1.9% | +6.7% |
| Current Liabilities | $50.52B |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $6.51B | — | — |
| Capital Expenditures | $1.91B | — | — |
| Investing Cash Flow | -$1.36B | — | — |
| Financing Cash Flow | $629.0M | — | — |
| Free Cash Flow | $4.60B | — | — |
| +2.1% |
| Long-term Debt | $31.24B | +8.9% | +24.9% |
| Total Liabilities | $90.10B | -2.0% | +7.1% |
| Stockholders' Equity | -$2.62B | +5.3% | -14.7% |